Biopesticides are biological pest control agents that are viewed as safer alternatives to the synthetic chemicals that dominate the global insecticide market. A major constraint on the wider adoption of biopesticides is their susceptibility to the ultraviolet (UV: 290-400 nm) radiation in sunlight, which limits their persistence and efficacy. Here, we describe a novel formulation technology for biopesticides in which the active ingredient (baculovirus) is micro-encapsulated in an ENTOSTAT wax combined with a UV absorbant (titanium dioxide, TiO 2). Importantly, this capsule protects the sensitive viral DNA from degrading in sunlight, but dissolves in the alkaline insect gut to release the virus, which then infects and kills the pest. We show, using simulated sunlight, in both laboratory bioassays and trials on cabbage and tomato plants, that this can extend the efficacy of the biopesticide well beyond the few hours of existing virus formulations, potentially increasing the spray interval and/or reducing the need for high application rates. The new formulation has a shelf-life at 30 °C of at least 6 months, which is comparable to standard commercial biopesticides and has no phytotoxic effect on the host plants. Taken together, these findings suggest that the new formulation technology could reduce the costs and increase the efficacy of baculovirus biopesticides, with the potential to make them commercially competitive alternatives to synthetic chemicals. Baculoviruses are dsDNA viruses that infect insects and have, since the 1980s, been used in crop protection as commercial biological insecticides 1,2. Baculoviruses are seen as attractive biological control agents against insect crop pests for many reasons: they have a long and detailed history of research, so basic knowledge of their taxonomy, biology and pathogenicity is available 3 ; they have an established profile of safety and environmental acceptability 4 ; they are highly efficacious pathogens of some of the world's most important crop pests, such as the various Heliothis / Helicoverpa species, Spodoptera spp. and Plutella xylostella 5 ; and, finally, their use as biological pesticides is feasible because commercially-viable mass production systems are well advanced for many baculoviruses 6. These factors have motivated the establishment of a growing commercial production of baculovirus insecticides in the Americas, Europe, Asia, Australasia and Africa 5,7. Moreover, biopesticides are now seen as a major candidate for replacing the many chemical pesticides that have been, and continue to be, withdrawn from the market due to safety concerns 5,8 , and/or where the insect pests have developed resistance to conventional chemical pesticides 9. Baculovirus products, however, still represent only a $50-70 million per annum sector of a global biopesticides market estimated to be worth $2.8 billion dollars a year 10. While a number of factors have been identified as restricting the adoption and expansion of the use of baculovirus biopesticides by growers 5 , a centr...